Publications by authors named "Virginia Kelly"

Claim this Profile
T
Temozolomide in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Retrospective Review.
David L Chan, Emily K Bergsland, Jennifer A Chan, Rujuta Gadgil, Thorvardur R Halfdanarson, Virginia Kelly

Oncologist· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade in Advanced Adrenocortical Carcinoma.
Nitya Raj, Youyun Zheng, Virginia Kelly, Seth S Katz, Joanne Chou, Kelly Olino

J Clin Oncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success of Direct-Acting, Antiviral-Based Therapy for Chronic Hepatitis C Is Not Affected by Type 2 Diabetes.
Blake A Niccum, Jonathan G Stine, Javelle A Wynter, Virginia Kelly, Stephen H Caldwell

Clin Diabetes· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.
Ian W Flinn, Carole B Miller, Kirit M Ardeshna, Scott Tetreault, Sarit E Assouline, Virginia M Kelly

J Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.
Ian W Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Árpád Illés, Virginia M Kelly

Blood· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study.
Ian W Flinn, Manish Patel, Yasuhiro Oki, Steven Horwitz, Francine F Foss, Patrick Kelly, Virginia M Kelly

Am J Hematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.
Susan O'Brien, Manish Patel, Brad S Kahl, Steven M Horwitz, Francine M Foss, Patrick Kelly, Virginia Kelly

Am J Hematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression.
Gregory K Friedman, Joshua D Bernstock, Dongquan Chen, Li Nan, Blake P Moore, Virginia M Kelly

Sci Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability.
Nitya Raj, Ronak Shah, Zsofia Stadler, Semanti Mukherjee, Joanne Chou, Virginia Kelly

JCO Precis Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies.
Ian W Flinn, Susan O'Brien, Brad Kahl, Manish Patel, Yasuhiro Oki, Virginia M Kelly, Patrick Kelly

Blood· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.
Steven M Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison Moskowitz, Patrick Kelly, Virginia Kelly

Blood· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002.
Eric K Ring, Rong Li, Blake P Moore, Li Nan, Virginia M Kelly

Mol Ther Oncolytics· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to "HbA1c levels as a parameter of glycemic control in patients with liver cirrhosis".
Jonathan G Stine, Javelle A Wynter, Blake Niccum, Virginia Kelly, Stephen H Caldwell

Ann Hepatol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C.
Jonathan G Stine, Javelle A Wynter, Blake Niccum, Virginia Kelly, Stephen H Caldwell

Ann Hepatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
Gregory K Friedman, Blake P Moore, Li Nan, Virginia M Kelly, Tina Etminan

Neuro Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose.
Karthik Venkatakrishnan, Tae Min Kim, Chia-Chi Lin, Lim Soon Thye, Wee Joo Chng, Virginia Kelly

Invest New Drugs· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series.
Scott L Cornella, Jonathan G Stine, Virginia Kelly, Stephen H Caldwell, Neeral L Shah

Postgrad Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus infection.
Neeral L Shah, Virginia Kelly, Stephen H Caldwell

Ann Intern Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.
Michael L Megison, Lauren A Gillory, Jerry E Stewart, Hugh C Nabers, Elizabeth Mroczek-Musulman, Virginia Kelly

PLoS One· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up.
Carlo Gambacorti-Passerini, Tim H Brümmendorf, Dong-Wook Kim, Anna G Turkina, Tamas Masszi, Virginia Kelly

Am J Hematol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.
Lauren A Gillory, Michael L Megison, Jerry E Stewart, Elizabeth Mroczek-Musulman, Hugh C Nabers, Virginia Kelly

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors.
Hagop M Kantarjian, Jorge E Cortes, Dong-Wook Kim, H Jean Khoury, Tim H Brümmendorf, Virginia Kelly

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.
Gregory K Friedman, Joel Raborn, Virginia M Kelly, Kevin A Cassady, James M Markert

Front Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in chronic myeloid leukemia.
Peter C Trask, David Cella, Christine Powell, Arlene Reisman, Jennifer Whiteley, Virginia Kelly

Leuk Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.
Gregory K Friedman, Marilyn C Haas, Virginia M Kelly, James M Markert, George Yancey Gillespie

Transl Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis